INTRODUCTION {#sec1}
============

Cancer has become a leading cause of death in China in recent decades^[@cit0001]^. A number of epidemiology studies have demonstrated that most cancers are attributable to a modifiable lifestyle and environmental risk factors, among which smoking is the largest preventable one^[@cit0002]--[@cit0005]^. Smoking, with a long-term adverse impact on health, has taken a great toll, of about 1 million deaths per year, on China and this is expected to exceed 3 million in 2050^[@cit0006]^. China is the world's largest producer and consumer of tobacco, with a population of 1.4 billion it has more than 301 million current smokers^[@cit0007]^. Due to substantial geographical variation in smoking prevalence, the burden of smoking related cancer across provinces remains unclear. In a previous study, we reported for the first time a systematic evaluation of the number of cancer cases and deaths attributable to carcinogens in 2005 in China^[@cit0008]^. In that study, we calculated the cancer cases and deaths attributable to smoking at the national level, but not at the provincial level. It is valuable to assess the local cancer burden caused by tobacco use as province-level initiatives are at the forefront of tobacco control, as indicated in the Lortet-Tieulent et al.^[@cit0009]^ study. However, most studies estimating smoking-related cancer mortality have been at the national level, and limited studies exist at the provincial level^[@cit0010]--[@cit0013]^.

Here, we provide an additional systematic assessment of cancer deaths attributable to smoking at the provincial level in China in 2013, aiming to provide scientific evidence for local policy makers to take effective action in tobacco control and cancer prevention.

METHODS {#sec2}
=======

Overview {#sec2.1}
--------

We estimate the province-specific proportion of cigarette smoking-related cancer mortality using similar methods in previous reports^[@cit0008],[@cit0010]^. We selected 10 cancers caused by cigarette smoking that have been classified established targets of the carcinogenicity of tobacco by the International Agency for Research on Cancer (IARC) including: cancers of mouth/pharynx/larynx, nasopharynx, lung, stomach, liver, esophagus, pancreas, colorectum, bladder, and kidney.

Cancer deaths {#sec2.2}
-------------

Data on cancer deaths in China in 2013 were based on the 255 qualified cancer registries distributed in the 31 provinces (autonomous regions and municipalities) of the annual cancer report of National Cancer Center, covering 226494490 of the population (including 114860339 males and 111634151 females) that accounted for 16.65% of the national population in 2013. In each province, cancer death rates were calculated by age group, sex, and cancer site. The death rates with sex-specific, age-specific and province-specific populations in 2013 were extrapolated to estimate the number of cancer deaths in each province. Finally, cancer death cases were calculated by summing the cases across all age groups and cancer sites in each province. This study is based on previously published data and does not include new human data that require again ethical approval and consent. The authors assume that the data source studies were conducted after ethical approval and consent, and in accordance with the Declaration of Helsinki 1975. The authors can confirm that all relevant data are included in the article and materials are available on request from the corresponding author.

Latency time and smoking prevalence {#sec2.3}
-----------------------------------

The occurrence of current cancers always reflects the past patterns of sustained smoking exposure, therefore there is a latency period between exposure and cancer. To date, no accurate studies are available to define the specific latency time between smoking and cancers. A report of World Health Organization (WHO) in 2000 suggested a latency time of 15 years^[@cit0014]^. Therefore, we used the smoking prevalence data of 1998.

Our study used a linear interpolation method to estimate provincial smoking prevalence in 1998 of data from two national surveys, in 1996 and 2002^[@cit0015],[@cit0016]^, based on the previous study^[@cit0010]^. In our study, smoking was identified as 'continuous or cumulative smoking of at least one cigarette every day for 6 months or more during the lifetime'^[@cit0017]^. Accordingly, we used the overall smoking status to represent smoking exposure, irrespective of current or former smoking status, type, amount, and duration of smoking.

Relative risk {#sec2.4}
-------------

Data on relative risks (RRs) were obtained from different sources, including PubMed and China National Knowledge Infrastructure (CNKI), in Chinese or English. High-quality meta-analyses or large-scale pooled analyses from the Chinese population were given the highest priority for RRs between smoking and specific types of cancer mortality, followed by meta-analyses from Asian populations. For most cancers associated with smoking, the RRs used in our study were obtained from a large-scale pooled analysis of smoking and cancer in populations of China and South Korea^[@cit0018]^. However, RR for smoking and kidney cancer mortality in men was from a meta-analysis among the Asian population^[@cit0019]^, and RR for smoking and esophageal cancer in women was abstracted from a prospective study in Linxian, China^[@cit0020]^ ([Table 1](#t0001){ref-type="table"}).

###### 

Relative risks of site-specific smoking-related cancers in China 2013

  *Cancer site*                              *ICD-10 code*   *Study[^a^](#tf1-1){ref-type="table-fn"}*   *Design*            *Age (years)*   *RR (95% CI)*       
  ------------------------------------------ --------------- ------------------------------------------- ------------------- --------------- ------------------- -----------------------------------------------------
  Mouth/larynx/                              C00-C10         \[18\]                                      Pooled-analysis     ≥45             1.95 (1.51--2.5)    1.99 (1.11--3.59)
  Pharynx                                    C12-C14                                                                                                             
  Stomach                                    C15             \[18\]                                      Pooled-analysis     ≥45             1.43 (1.24--1.64)   1.14 (1.08--1.52)
  Colorectal                                 C18-C20         \[18\]                                      Pooled-analysis     ≥45             1.13 (0.93--1.37)   1.40 (1.08--1.83)
  Liver                                      C22             \[18\]                                      Pooled-analysis     ≥45             1.35 (1.19--1.53)   1.75 (1.05--2.84)
  Pancreas                                   C25             \[18\]                                      Pooled-analysis     ≥45             1.18 (0.75--1.86)   1.65 (1.08--2.53)
  Lung                                       C33-C34         \[18\]                                      Pooled-analysis     ≥45             3.56 (2.45--5.16)   3.34 (2.29--4.86)
  Bladder                                    C67             \[18\]                                      Pooled-analysis     ≥45             1.97 (1.26--3.06)   1.41 (0.56--3.52)
  Kidney[^b^](#tf1-2){ref-type="table-fn"}   C64             \[19\]                                      Meta-analysis       \-              1.11 (0.85--1.47)   1.11 (0.85--1.47)
  Nasopharynx                                C11             \[18\]                                      Pooled-analysis     ≥45             2.22 (1.42--3.49)   2.22 (1.42--3.49)
  Esophagus                                  C15             \[18\]                                      Pooled-analysis     ≥45             1.54 (0.66--3.57)   \-
                                                             \[20\]                                      Prospective study   40--69          \-                  1.34 (1.16--1.54)[^c^](#tf1-3){ref-type="table-fn"}

Zheng et al.^[@cit0018]^, Cumberbatch et al.^[@cit0019]^ and Tran et al.^[@cit0020]^.

RR was derived from the Asian population.

RR for female esophageal cancer associated with smoking was obtained from a prospective study in Linxian, China^[@cit0020]^.

Statistical analysis {#sec2.5}
--------------------

Population attributable fraction (PAF) is defined as the proportional reduction of disease incidence or mortality in a population that would occur if exposure to a risk factor is reduced to an alternative ideal exposure scenario (e.g. no tobacco use)^[@cit0021]^. PAF was calculated according to Levin's formula, in which p represents the prevalence of exposure to the risk factor in the total population, and RR represents the relative risk of a risk factor, where:
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Finally, the overall PAF in each province was calculated by dividing the number of estimated smoking-attributable cancer deaths by the total number of cancer deaths among persons aged ≥30 years, in each province.

RESULTS {#sec3}
=======

In 2013, smoking contributed to a total of 421566 cancer deaths (19.46% of all cancer deaths) in mainland China, with 400701 of these deaths occurring in men (29.34%) and 21368 (2.67%) in women ([Table 2](#t0002){ref-type="table"}).

###### 

Population (N), smoking prevalence (%), cancer deaths (CD), number and proportion of smoking-attributable cancer deaths (SACD), China 2013

  *Region*         *Province*   *N*         *%*       *CD*     *SACD*                 *PAF % (95% CI)*       *PAF rank*
  ---------------- ------------ ----------- --------- -------- ---------------------- ---------------------- ------------
  **Men**                                                                                                    
  **Northern**     Beijing      10126430    66.82     20426    5967                   29.21 (19.89--41.19)   16
  Tianjin          6907091      59.71       13046     4066     31.17 (21.85--42.44)   6                      
  Hebei            36430286     63.41       65439     18165    27.76 (18.25--39.88)   22                     
  Shanxi           18338760     64.97       33416     9968     29.83 (18.79--44.60)   13                     
  Inner Mongolia   12838243     69.28       24398     7494     30.72 (19.79--45.18)   7                      
  **Northeast**    Liaoning     22147745    54.70     53673    15198                  28.32 (18.72--40.34)   21
  Jilin            13907218     64.39       24847     7863     31.65 (22.20--42.76)   4                      
  Heilongjiang     19426106     59.76       43269     13173    30.44 (21.05--42.01)   9                      
  **Eastern**      Shanghai     11854916    64.90     38578    9949                   25.79 (17.07--37.01)   26
  Jiangsu          39626707     61.78       79512     21920    27.57 (16.66--42.67)   23                     
  Zhejiang         27965641     63.22       65728     20006    30.44 (20.72--42.70)   9                      
  Anhui            30245513     62.02       67127     20583    30.66 (19.11--45.71)   8                      
  Fujian           18981054     61.47       41173     10898    26.47 (16.21--40.01)   24                     
  Jiangxi          23003521     62.96       37340     10922    29.25 (19.99--40.20)   15                     
  Shandong         48446944     55.78       119352    34230    28.68 (18.27--42.41)   18                     
  **Central**      Henan        47493063    63.10     90311    26199                  29.01 (17.95--43.82)   17
  Hubei            29391247     65.03       64673     20533    31.75 (21.88--43.75)   3                      
  Hunan            33776459     63.72       52206     16417    31.45 (22.40--41.67)   5                      
  **Southern**     Guangdong    54400538    66.04     92992    28205                  30.33 (20.67--41.82)   12
  Guangxi          23924704     57.54       47584     13515    28.40 (19.20--39.04)   19                     
  Hainan           4592283      54.30       8876      2112     23.79 (15.63--32.88)   30                     
  **Southwest**    Chongqing    14608870    66.66     34925    12164                  34.83 (23.38--49.80)   2
  Sichuan          40827834     63.38       95297     28125    29.51 (18.48--44.24)   14                     
  Guizhou          17905471     73.82       23344     8191     35.09 (25.68--45.83)   1                      
  Yunnan           23856696     75.48       35566     10803    30.37 (21.41--41.41)   11                     
  Tibet            1542652      47.67       559       87       15.56 (9.12--21.82)    31                     
  **Northwest**    Shaanxi      19287575    63.50     35344    10014                  28.33 (16.88--44.28)   20
  Gansu            13064193     62.76       32955     7968     24.18 (13.48--38.87)   29                     
  Qinghai          2913793      67.45       4078      1048     25.70 (16.14--37.96)   27                     
  Ningxia          3227404      59.38       4602      1213     26.36 (17.08--38.16)   25                     
  Xinjiang         11270147     50.36       14917     3705     24.84 (16.06--36.03)   28                     
  National         682329104                1365553   400701   29.34 (19.21--42.31)                          
  **Women**                                                                                                  
  **Northern**     Beijing      9485938     6.93      14279    670                    4.69 (1.90--7.71)      5
  Tianjin          6031602      11.56       9599      901      9.39 (4.49--14.52)     2                      
  Hebei            35423924     5.55        39607     1431     3.61 (1.51--5.85)      6                      
  Shanxi           17373341     2.56        18375     285      1.55 (0.55--2.67)      21                     
  Inner Mongolia   11868048     12.50       12667     1182     9.33 (4.19--14.77)     3                      
  **Northeast**    Liaoning     21598578    5.45      47353    1550                   3.27 (1.29--5.35)      8
  Jilin            13545597     14.91       16577     1730     10.44 (4.86--16.32)    1                      
  Heilongjiang     18887885     10.67       29662     2544     8.58 (3.78--13.64)     4                      
  **Eastern**      Shanghai     11164280    2.09      27631    324                    1.17 (0.29--2.15)      25
  Jiangsu          39034234     3.53        45097     1002     2.22 (0.81--3.75)      13                     
  Zhejiang         26461250     1.90        35320     481      1.36 (0.42--2.37)      24                     
  Anhui            29254955     4.08        33289     811      2.44 (0.89--4.13)      10                     
  Fujian           17913163     0.82        18249     89       0.49 (0.10--0.91)      30                     
  Jiangxi          21564276     2.42        19975     308      1.54 (0.48--2.67)      22                     
  Shandong         47345775     2.73        66521     1448     2.18 (0.85--3.58)      14                     
  **Central**      Henan        46536876    1.39      61735    549                    0.89 (0.29--1.53)      28
  Hubei            27846480     2.71        33938     651      1.92 (0.67--3.29)      18                     
  Hunan            31924303     3.11        28374     575      2.03 (0.72--3.43)      16                     
  **Southern**     Guangdong    49919921    2.54      53371    1023                   1.92 (0.62--3.28)      18
  Guangxi          22099057     2.03        22450     331      1.47 (0.46--2.57)      23                     
  Hainan           4079202      0.53        4657      13       0.28 (0.00--0.64)      31                     
  **Southwest**    Chongqing    14237300    2.88      18652    428                    2.29 (0.88--3.80)      12
  Sichuan          39589694     2.77        49805     974      1.96 (0.69--3.30)      17                     
  Guizhou          16843085     2.76        14640     340      2.32 (0.75--4.00)      11                     
  Yunnan           22110070     3.65        24683     504      2.04 (0.66--3.52)      15                     
  Tibet            1459513      6.97        399       4        1.00 (0.25--2.01)      27                     
  **Northwest**    Shaanxi      18039804    1.94      19929    222                    1.11 (0.39--1.90)      26
  Gansu            12511070     1.67        19858     151      0.76 (0.24--1.36)      29                     
  Qinghai          2712930      2.90        2366      37       1.56 (0.42--2.92)      20                     
  Ningxia          3073946      4.93        2536      84       3.31 (1.26--5.60)      7                      
  Xinjiang         10545668     3.85        8993      223      2.48 (0.88--4.24)      9                      
  National         650481765                800587    20865    2.61 (1.01--4.31)                             
  **Total**                                                                                                  
  **Northern**     Beijing      19612368    37.85     34705    6637                   19.12 (12.49--27.41)   17
  Tianjin          12938693     37.26       22645     4967     21.93 (14.49--30.61)   5                      
  Hebei            71854210     34.88       105046    19596    18.65 (11.94--27.05)   19                     
  Shanxi           35712101     34.61       51791     10253    19.80 (12.32--29.72)   13                     
  Inner Mongolia   24706291     42.00       37065     8676     23.41 (14.46--34.79)   2                      
  **Northeast**    Liaoning     43746323    30.39     101026   16748                  16.58 (10.55--23.94)   26
  Jilin            27452815     39.97       41424     9593     23.16 (15.26--32.18)   3                      
  Heilongjiang     38313991     35.56       72931     15717    21.55 (14.03--30.47)   6                      
  **Eastern**      Shanghai     23019196    34.43     66209    10273                  15.52 (10.07--22.46)   29
  Jiangsu          78660941     32.88       124609    22922    18.40 (10.92--28.58)   22                     
  Zhejiang         54426891     33.41       101048    20487    20.27 (13.62--28.60)   10                     
  Anhui            59500468     33.54       100416    21394    21.31 (13.07--31.93)   8                      
  Fujian           36894217     32.02       59422     10987    18.49 (11.26--28.00)   21                     
  Jiangxi          44567797     33.66       57315     11230    19.59 (13.19--27.12)   15                     
  Shandong         95792719     29.56       185873    35678    19.19 (12.03--28.52)   16                     
  **Central**      Henan        94029939    32.56     152046   26748                  17.59 (10.78--26.65)   24
  Hubei            57237727     34.71       98611     21184    21.48 (14.58--29.83)   7                      
  Hunan            65700762     34.27       80580     16992    21.09 (14.77--28.21)   9                      
  **Southern**     Guangdong    104320459   35.65     146363   29228                  19.97 (13.36--27.77)   12
  Guangxi          46023761     30.89       70034     13846    19.77 (13.20--27.35)   14                     
  Hainan           8671485      28.07       13533     2125     15.70 (10.25--21.78)   28                     
  **Southwest**    Chongqing    28846170    35.83     53577    12592                  23.50 (15.55--33.79)   1
  Sichuan          80417528     34.87       145102    29099    20.05 (12.37--30.19)   11                     
  Guizhou          34748556     38.75       37984     8531     22.46 (16.07--29.71)   4                      
  Yunnan           45966766     40.12       60249     11307    18.77 (12.91--25.89)   18                     
  Tibet            3002165      27.94       958       91       9.50 (5.43--13.57)     31                     
  **Northwest**    Shaanxi      37327379    33.89     55273    10236                  18.52 (10.93--29.00)   20
  Gansu            25575263     33.06       52813     8119     15.37 (8.50--24.77)    30                     
  Qinghai          5626723      36.25       6444      1085     16.84 (10.37--25.09)   25                     
  Ningxia          6301350      32.74       7138      1297     18.17 (11.46--26.59)   23                     
  Xinjiang         21815815     27.93       23910     3928     16.43 (10.35--24.07)   27                     
  National         1332810869               2166140   421566   19.46 (12.49--28.26)                          

CI: confidence interval. PAF: population attributable fraction. SACD: smoking attributable cancer deaths.

For the sexes combined, the faction of cancer deaths attributable to smoking was highest in Inner Mongolia, Chongqing, Jilin and Guizhou, and PAF ranged from 22.46% to 23.50% ([Table 2](#t0002){ref-type="table"}; and Supplementary file, Figure S1). However, the patterns of PAFs were different between men and women, ranging from 15.56% (95% CI: 9.12--21.82%) in Tibet to 35.09% (95% CI: 25.68--45.83%) in Guizhou among men, and from 0.28% (95% CI: 0.00--0.64%) in Hainan to 10.44% (95% CI: 4.86--16.32%) in Jilin among women ([Table 2](#t0002){ref-type="table"}). In men, the top 4 PAFs ranged from 35.09% to 31.65%, for provinces in the Southwest and Northeast regions including Guizhou, Chongqing, Hubei, and Jilin. In women, however, the topmost 4 provinces (Jilin, Tianjin, Inner Mongolia, and Heilongjiang) were located in Northern China, and PAF ranged from 8.58% to 10.44%, which was three-fold of the national average ([Figure 1](#f0001){ref-type="fig"}).

![Rank of smoking-attributable cancer mortality in 2013 by gender](TID-18-49-g001){#f0001}

We also present the site-specific smoking-attributable cancer deaths and the corresponding proportions in 31 provinces among men and women ([Figures 2](#f0002){ref-type="fig"} and [3](#f0003){ref-type="fig"}; and Supplementary file, Figures S2 and S3). Overall, cancers of lung and liver were the two main causes of smoking-related cancer deaths for both men and women. For men, stomach cancer was the third cause of smoking-related cancer deaths, followed by cancers of esophagus, mouth/larynx/pharynx, nasopharynx, bladder, colorectum, pancreas, and kidney. For women, colorectal cancer was the third cause of smoking-related cancer deaths, followed by cancers of pancreas, esophagus, stomach, mouth/larynx/pharynx, nasopharynx, bladder, and kidney. The number and proportion of site-specific smoking-attributable cancer deaths varied substantially across provinces.

![Heatmap of site-specific cancer deaths in the 31 provinces of mainland China in 2013 in men](TID-18-49-g002){#f0002}

![Heatmap of site-specific cancer deaths in the 31 provinces of mainland China in 2013 in women](TID-18-49-g003){#f0003}

DISCUSSION {#sec4}
==========

This study provides a systematic evidence-based assessment of province-specific smoking-attributable cancer burden in China. Smoking-attributable cancer mortality in men (PAF=29.34%; 95%CI: 19.21--42.31%) was substantially higher than that in women (PAF=2.61%; 95%CI: 1.01--4.31%), which is mainly explained by the higher smoking prevalence in men. Overall, smoking was responsible for approximately 20% in all cancer deaths in mainland China, but this proportion of smoking-attributable cancer deaths varied substantially across provinces.

Regional variation in PAFs can be primarily explained by differences in smoking prevalence, which has prevailed partly due to variations in tobacco control policies and programs, socioeconomic status and education, culture, and attitudes. Since China ratified the WHO Framework Convention on Tobacco Control in 2005, some metropolitan cities have adopted smoke-free laws prohibiting smoking in public areas. However, the implementation and compliance of smoke-free policy has shown large differences on the subnational level^[@cit0023]^. Tobacco control policies are heavily influenced by the tobacco industry in all provinces, and tobacco use prevalences are higher in the cities near where tobacco is grown, such as in the Yunnan and Guizhou provinces. However, higher smoking prevalences in the Northeast regions, with nearly no tobacco plantations, can be explained by low smoking cessation rates and low cost of manufactured cigarettes there^[@cit0024]^. Moreover, low socioeconomic status is considered to be associated with higher smoking prevalence and lower smoking cessation rates^[@cit0025],[@cit0026]^. People with lower educational levels are less aware of the adverse effects of smoking. Generally, cigarettes are a popular 'social currency' in China, especially in the rural regions^[@cit0027],[@cit0028]^.

The larger burden of smoking-related cancer deaths in men than in women most likely reflects the higher prevalence of smoking among men than in women, but there are large discrepancies in PAFs among women across provinces. PAFs among women living in the Southwest provinces were approximately 2--3%, which were lower than the national average, compared with that in men of Southwest China. Moreover, tobacco control policies and programmes appeared not to be well implemented in Northern China. The topmost 4 provinces (Jilin, Tianjin, Inner Mongolia, and Heilongjiang) had PAFs that were three-fold higher than the national average among women, and the top nine provinces with higher PAFs were all located north of the Yangtze River.

The order of site-specific cancer deaths in China has changed in the past decades^[@cit0029]^, but lung cancer have ranked as first in the smoking-attributable cancer deaths for both genders, consistent with the results from other developing countries^[@cit0030]^. The tobacco epidemic was responsible for the rapid increase in lung cancer mortality in recent decades^[@cit0031]^. However, in some provinces, we found that smoking contributed more deaths from cancers of the stomach and esophagus than liver cancer among men, which was driven by the higher mortality rates of stomach and esophageal cancers in these regions.

Our province-specific PAF estimates were comparable with those from the limited evidence available from previous studies in China based on similar methodology. In our study, estimates of provincial PAFs for smoking and cancer deaths in men were higher than the corresponding figures of a previous study^[@cit0032]^. This discrepancy can be primarily explained by different sources of smoking prevalence. Our study used the smoking prevalence in 1998 as the exposure rate, which was higher than the figures of 2002 used in the Xia et al.^[@cit0032]^ study, based on a different assumption of the latency time. Although the smoking definitions were similar in both studies, there were some differences in how PAF values were estimated. For smoking-related cancers, we included 10 cancer sites in our study versus 5 major cancer sites together with other minor sites in the Xia et al.^[@cit0032]^ study. In addition, the estimates of smoking attributable cancer mortality could be affected by the time fluctuation of cancer registered data and different sources of RRs. For most cancers, RRs used in our estimates were abstracted from the results of the Chinese population in a pooled analysis of 21 cohort studies in Asia, which were relatively lower than those in the Western population^[@cit0033],[@cit0034]^, but higher than those in the Xia et al.^[@cit0032]^ study. In their study, RRs were taken from the China Kadoorie Biobank Study from 10 regions during 7 years of follow-up^[@cit0035]^, which might be underestimated due to the short period of follow-up. Regardless of the PAF disparities, the order of provincial PAFs was still comparable in the two studies (Supplementary file, Figure S4).

In China, smoking prevalence in men declined rapidly during the 1980s and 1990s. Nevertheless, the fraction of smoking-attributable cancer mortality increased slightly over time. The Liu et al.^[@cit0036]^ study in 1990 reported a fraction of 24.4% in men, but the corresponding figures were 28.0% and 32.7% in 2005 in the Gu et al.^[@cit0012]^ study and the Wang et al.^[@cit0008]^ study, respectively. There might be potential overestimation in relative risk for lung cancer sourced from limited Shanghai residents used in the Wang et al.^[@cit0008]^ study. Methodological differences might be a source of disparity, but potential transition in stages of smoking-related cancer might be a greater contributor. Moreover, our PAF estimates were comparable with the results from the Western populations^[@cit0037]^, while smoking prevalence was relatively higher in Chinese men^[@cit0007],[@cit0015],[@cit0016]^. In China, widespread tobacco smoking began several decades later than in Europe and North America, thus China was at an earlier stage of the tobacco epidemic compared with the developed countries^[@cit0038]^. In recent years, smoking prevalence has declined slowly in China due to enforcement of tobacco control policies, but still remains high, especially in men. The current smoke-free policy is still inadequate in reducing prevalence and affecting smoker's behavior^[@cit0039]^. As the tobacco epidemic grows, smoking associated cancer deaths will be elevated due to the long latency time of smoking related cancers. More effective efforts in tobacco control, including increasing tobacco taxes and maintaining funding of anti-smoking campaigns, are needed to reduce the smoking-related cancer burden.

Strengths and limitations {#sec4.1}
-------------------------

A strength of our study is the estimate of site-specific smoking attributable cancer mortality at the provincial level. However, our study has also several limitations and uncertainty. First, in our study, indirect smoking prevalence data were used due to lack of qualified age-specific data on provincial smoking prevalence and smoking prevalence based on self-reported results can be underestimated^[@cit0040]^, which could affect our estimates. Second, only 10 major types of smoking-related cancers were included in our study, and some other smoking-associated cancers were excluded due to the lack of reliable data, so that our PAF values might be underestimated. Third, secondhand smoking also plays a crucial role in the association of smoking and lung cancer, but it was not included in our study because it is difficult to quantify and there are no corresponding reliable provincial data based on latency time. However, in our previous study, we estimated that 11.1% of lung cancer deaths among non-smoking women were attributable to involuntary smoking from the spouse or at the workplace^[@cit0010]^, which is very comparable with that of the Xia et al.^[@cit0032]^ study (11.5%). Finally, in our study, we only considered smoking status as never or ever, and were not able to collect information on the type, starting age, amount and duration of smoking. However, using alternative definitions of smoking may not substantially alter the PAF estimates based on the Xia et al.^[@cit0032]^ study.

CONCLUSIONS {#sec5}
===========

Our study provides a systematic assessment of province-specific cancer burden of tobacco smoking in China in 2013. We found that smoking was responsible for nearly 20% of cancer deaths in the Chinese population in 2013, and that the proportion of smoking-attributable cancer deaths varies across provinces. Our findings provide strong evidence for more effective programs and innovative new strategies for local tobacco control to reduce the high burden of smoking-related cancers in the provinces of mainland China.
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